468 related articles for article (PubMed ID: 8816428)
1. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response.
Early GS; Zhao W; Burns CM
J Immunol; 1996 Oct; 157(7):3159-64. PubMed ID: 8816428
[TBL] [Abstract][Full Text] [Related]
2. Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function.
Kalled SL; Cutler AH; Datta SK; Thomas DW
J Immunol; 1998 Mar; 160(5):2158-65. PubMed ID: 9498753
[TBL] [Abstract][Full Text] [Related]
3. Treatment of murine lupus with F(ab')2 fragments of monoclonal antibody to L3T4. Suppression of autoimmunity does not depend on T helper cell depletion.
Carteron NL; Schimenti CL; Wofsy D
J Immunol; 1989 Mar; 142(5):1470-5. PubMed ID: 2521880
[TBL] [Abstract][Full Text] [Related]
4. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis.
Mohan C; Shi Y; Laman JD; Datta SK
J Immunol; 1995 Feb; 154(3):1470-80. PubMed ID: 7529804
[TBL] [Abstract][Full Text] [Related]
5. Terminal deoxynucleotidyl transferase deficiency reduces the incidence of autoimmune nephritis in (New Zealand Black x New Zealand White)F1 mice.
Conde C; Weller S; Gilfillan S; Marcellin L; Martin T; Pasquali JL
J Immunol; 1998 Dec; 161(12):7023-30. PubMed ID: 9862739
[TBL] [Abstract][Full Text] [Related]
6. Resting B cells from autoimmune lupus-prone New Zealand Black and (New Zealand Black x New Zealand White)F1 mice are hyper-responsive to T cell-derived stimuli.
Jongstra-Bilen J; Vukusic B; Boras K; Wither JE
J Immunol; 1997 Dec; 159(12):5810-20. PubMed ID: 9550377
[TBL] [Abstract][Full Text] [Related]
7. Abrogation of pathogenic IgG autoantibody production in CD40L gene-deleted lupus-prone New Zealand Black mice.
Pau E; Chang NH; Loh C; Lajoie G; Wither JE
Clin Immunol; 2011 May; 139(2):215-27. PubMed ID: 21414847
[TBL] [Abstract][Full Text] [Related]
8. Blockade of programmed death-1 in young (New Zealand black x New Zealand white)F1 mice promotes the activity of suppressive CD8+ T cells that protect from lupus-like disease.
Wong M; La Cava A; Singh RP; Hahn BH
J Immunol; 2010 Dec; 185(11):6563-71. PubMed ID: 21041733
[TBL] [Abstract][Full Text] [Related]
9. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
Liang B; Gardner DB; Griswold DE; Bugelski PJ; Song XY
Immunology; 2006 Nov; 119(3):296-305. PubMed ID: 17067309
[TBL] [Abstract][Full Text] [Related]
10. Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers.
Han S; Hathcock K; Zheng B; Kepler TB; Hodes R; Kelsoe G
J Immunol; 1995 Jul; 155(2):556-67. PubMed ID: 7541819
[TBL] [Abstract][Full Text] [Related]
11. Treatment of murine lupus with monoclonal antibody to L3T4. II. Effects on immunohistopathology of thymus, spleen, and lymph node.
Ermak TH; Steger HJ; Wofsy D
Lab Invest; 1989 Oct; 61(4):447-56. PubMed ID: 2529396
[TBL] [Abstract][Full Text] [Related]
12. Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule.
Nakajima A; Azuma M; Kodera S; Nuriya S; Terashi A; Abe M; Hirose S; Shirai T; Yagita H; Okumura K
Eur J Immunol; 1995 Nov; 25(11):3060-9. PubMed ID: 7489744
[TBL] [Abstract][Full Text] [Related]
13. Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides: tolerance spreading impairs pathogenic function of autoimmune T and B cells.
Kaliyaperumal A; Michaels MA; Datta SK
J Immunol; 1999 May; 162(10):5775-83. PubMed ID: 10229810
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of T and B cell collaboration in the in vitro production of anti-DNA antibodies in the NZB/NZW F1 murine SLE model.
Ando DG; Sercarz EE; Hahn BH
J Immunol; 1987 May; 138(10):3185-90. PubMed ID: 2952711
[TBL] [Abstract][Full Text] [Related]
15. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Buhlman J; Xu J; Flavell RA; Korngold R; Noelle R; Vallera DA
J Immunol; 1997 Jan; 158(1):29-39. PubMed ID: 8977172
[TBL] [Abstract][Full Text] [Related]
16. CD4+ T cell lines with selective patterns of autoreactivity as well as CD4- CD8- T helper cell lines augment the production of idiotypes shared by pathogenic anti-DNA autoantibodies in the NZB x SWR model of lupus nephritis.
Sainis K; Datta SK
J Immunol; 1988 Apr; 140(7):2215-24. PubMed ID: 2965184
[TBL] [Abstract][Full Text] [Related]
17. T helper cells driving pathogenic anti-DNA autoantibody production in lupus: nucleosomal epitopes and CD40 ligand signals.
Datta SK; Kaliyaperumal A; Mohan C; Desai-Mehta A
Lupus; 1997; 6(3):333-6. PubMed ID: 9296784
[No Abstract] [Full Text] [Related]
18. B cell apoptosis accelerates the onset of murine lupus.
Trébéden-Nègre H; Weill B; Fournier C; Batteux F
Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
[TBL] [Abstract][Full Text] [Related]
19. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
[TBL] [Abstract][Full Text] [Related]
20. Treatment of lupus in NZB/W F1 mice with monoclonal antibody against Fas ligand.
Nakajima A; Hirai H; Kayagaki N; Yoshino S; Hirose S; Yagita H; Okumura K
J Autoimmun; 2000 Mar; 14(2):151-7. PubMed ID: 10677246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
